Medifast (MED) Tops Q1 EPS by 12c, Misses on Revenue
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $10.60 -0.19%
EPS Growth %: -295.5%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -295.5%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q1 EPS of ($0.07), $0.12 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $115.7 million versus the consensus estimate of $130.75 million.
GUIDANCE:
Medifast sees Q2 2025 revenue of $85-105 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemours reaches $450M settlement over PFAS pollution at four sites
- Paychex beats fourth quarter EPS estimates, stock slides
- JPMorgan raises S&P 500 target to 7,800, says earnings revision ’unprecedented’
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
